eF-site ID 2at1-ABCD
PDB Code 2at1
Chain A, B, C, D

click to enlarge
Title CRYSTAL STRUCTURES OF PHOSPHONOACETAMIDE LIGATED T AND PHOSPHONOACETAMIDE AND MALONATE LIGATED R STATES OF ASPARTATE CARBAMOYLTRANSFERASE AT 2.8-ANGSTROMS RESOLUTION AND NEUTRAL PH
Classification TRANSFERASE (CARBAMOYL-P,ASPARTATE)
Compound ASPARTATE CARBAMOYLTRANSFERASE (R STATE), CATALYTIC CHAIN
Source Escherichia coli (strain K12) (PYRI_ECOLI)
Sequence A:  ANPLYQKHIISINDLSRDDLNLVLATAAKLKANPQPELLK
HKVIASCFFEASTRTRLSFQTSMHRLGASVVGFSDSANTS
LGKKGETLADTISVISTYVDAIVMRHPQEGAARLATEFSG
NVPVLNAGDGSNQHPTQTLLDLFTIQQTEGRLDNLHVAMV
GDLKYGRTVHSLTQALAKFDGNRFYFIAPDALAMPEYILD
MLDEKGIAWSLHSSIEEVMAEVDILYMTRVQKERLDPSEY
ANVKAQFVLRASDLHNAKANMKVLHPLPRVDEIATDVDKT
PHAWYFQQAGNGIFARQALLALVLNRDLVL
B:  GVEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLN
LPSGEMGRKDLIKIENTFLSEDQVDQLALYAPQATVNRID
NYEVVGKSRPSLPERIDNVLVCPNSNCISHAEPVSSSFAV
RKRANDIALKCKYCEKEFSHNVVLAN
C:  ANPLYQKHIISINDLSRDDLNLVLATAAKLKANPQPELLK
HKVIASCFFEASTRTRLSFQTSMHRLGASVVGFSDSANTS
LGKKGETLADTISVISTYVDAIVMRHPQEGAARLATEFSG
NVPVLNAGDGSNQHPTQTLLDLFTIQQTEGRLDNLHVAMV
GDLKYGRTVHSLTQALAKFDGNRFYFIAPDALAMPEYILD
MLDEKGIAWSLHSSIEEVMAEVDILYMTRVQKERLDPSEY
ANVKAQFVLRASDLHNAKANMKVLHPLPRVDEIATDVDKT
PHAWYFQQAGNGIFARQALLALVLNRDLVL
D:  GVEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLN
LPSGEMGRKDLIKIENTFLSEDQVDQLALYAPQATVNRID
NYEVVGKSRPSLPERIDNVLVCPNSNCISHAEPVSSSFAV
RKRANDIALKCKYCEKEFSHNVVLAN
Description


Functional site

1) chain A
residue 54
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

2) chain A
residue 55
type
sequence T
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

3) chain A
residue 105
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

4) chain A
residue 134
type
sequence H
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

5) chain A
residue 137
type
sequence Q
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

6) chain A
residue 167
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

7) chain A
residue 229
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

8) chain A
residue 231
type
sequence Q
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

9) chain A
residue 266
type
sequence P
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

10) chain A
residue 267
type
sequence L
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMA

11) chain B
residue 109
type
sequence C
description zn binding site
source : ZNB

12) chain B
residue 114
type
sequence C
description zn binding site
source : ZNB

13) chain B
residue 138
type
sequence C
description zn binding site
source : ZNB

14) chain B
residue 141
type
sequence C
description zn binding site
source : ZNB

15) chain C
residue 54
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

16) chain C
residue 55
type
sequence T
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

17) chain C
residue 105
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

18) chain C
residue 134
type
sequence H
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

19) chain C
residue 137
type
sequence Q
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

20) chain C
residue 167
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

21) chain C
residue 229
type
sequence R
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

22) chain C
residue 231
type
sequence Q
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

23) chain C
residue 266
type
sequence P
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

24) chain C
residue 267
type
sequence L
description BINDING SITES OF COMBINED *PCT* AND *MAL* MOLECULES. SITE ACTUALLY CONTAIN AN ADDITIONAL TWO RESIDUES OF SYMMETRY RELATED. THE OTHER RESIDUES, SER A 80, AND LYS A 84 ARE IN AN ADJACENT (THREE-FOLD RELATED) CATALYTIC CHAIN.
source : PMC

25) chain D
residue 109
type
sequence C
description zn binding site
source : ZND

26) chain D
residue 114
type
sequence C
description zn binding site
source : ZND

27) chain D
residue 138
type
sequence C
description zn binding site
source : ZND

28) chain D
residue 141
type
sequence C
description zn binding site
source : ZND

29) chain A
residue 55
type catalytic
sequence T
description 405
source MCSA : MCSA1

30) chain A
residue 56
type catalytic
sequence R
description 405
source MCSA : MCSA1

31) chain A
residue 85
type catalytic
sequence G
description 405
source MCSA : MCSA1

32) chain A
residue 106
type catalytic
sequence H
description 405
source MCSA : MCSA1

33) chain A
residue 135
type catalytic
sequence P
description 405
source MCSA : MCSA1

34) chain C
residue 55
type catalytic
sequence T
description 405
source MCSA : MCSA2

35) chain C
residue 56
type catalytic
sequence R
description 405
source MCSA : MCSA2

36) chain C
residue 85
type catalytic
sequence G
description 405
source MCSA : MCSA2

37) chain C
residue 106
type catalytic
sequence H
description 405
source MCSA : MCSA2

38) chain C
residue 135
type catalytic
sequence P
description 405
source MCSA : MCSA2

39) chain A
residue 48-55
type prosite
sequence FFEASTRT
description CARBAMOYLTRANSFERASE Aspartate and ornithine carbamoyltransferases signature. FfEaSTRT
source prosite : PS00097

40) chain B
residue 110
type BINDING
sequence P
description
source Swiss-Prot : SWS_FT_FI1

41) chain C
residue 106
type BINDING
sequence H
description
source Swiss-Prot : SWS_FT_FI1

42) chain C
residue 135
type BINDING
sequence P
description
source Swiss-Prot : SWS_FT_FI1

43) chain C
residue 138
type BINDING
sequence T
description
source Swiss-Prot : SWS_FT_FI1

44) chain C
residue 268
type BINDING
sequence P
description
source Swiss-Prot : SWS_FT_FI1

45) chain C
residue 269
type BINDING
sequence R
description
source Swiss-Prot : SWS_FT_FI1

46) chain B
residue 115
type BINDING
sequence I
description
source Swiss-Prot : SWS_FT_FI1

47) chain B
residue 139
type BINDING
sequence K
description
source Swiss-Prot : SWS_FT_FI1

48) chain B
residue 142
type BINDING
sequence E
description
source Swiss-Prot : SWS_FT_FI1

49) chain D
residue 110
type BINDING
sequence P
description
source Swiss-Prot : SWS_FT_FI1

50) chain D
residue 115
type BINDING
sequence I
description
source Swiss-Prot : SWS_FT_FI1

51) chain D
residue 139
type BINDING
sequence K
description
source Swiss-Prot : SWS_FT_FI1

52) chain D
residue 142
type BINDING
sequence E
description
source Swiss-Prot : SWS_FT_FI1

53) chain C
residue 56
type BINDING
sequence R
description
source Swiss-Prot : SWS_FT_FI1

54) chain A
residue 85
type BINDING
sequence G
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2

55) chain A
residue 168
type BINDING
sequence T
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2

56) chain A
residue 230
type BINDING
sequence V
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2

57) chain C
residue 85
type BINDING
sequence G
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2

58) chain C
residue 168
type BINDING
sequence T
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2

59) chain C
residue 230
type BINDING
sequence V
description BINDING => ECO:0000255|HAMAP-Rule:MF_00001, ECO:0000305|PubMed:3380787
source Swiss-Prot : SWS_FT_FI2


Display surface

Download
Links